Hyperventilation in Patients With Chronic Low Back Pain (HELBP)

September 26, 2023 updated by: Lotte Janssens, Hasselt University
Low back pain (LBP) is the leading cause of disability worldwide. Impaired postural control is a key factor in the development and maintenance of LBP. Moreover, the prevalence of LBP is associated with impairments in diaphragm function, symptoms of dyspnea, and dysfunctional breathing. However, the association between LBP (and more specifically postural control) and hyperventilation remains unknown. The main objective of this project is to investigate whether the presence of recurrent non-specific LBP is related to the presence of hyperventilation, when classified either objectively by decreased carbon dioxide values (demonstrating hypocapnia) or by symptoms while showing normal carbon dioxide values. Moreover, the investigators will explore whether psychosocial factors play a role in this relation. Subsequently, the investigators will examine whether hyperventilation in LBP patients is related to impaired postural control, and more specifically to a decreased postural contribution of the diaphragm.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Hasselt, Belgium, 3590
        • Recruiting
        • Hasselt University
        • Contact:
          • Lotte Janssens, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria Patients:

  • Chronic primary low back pain (>12 weeks) as diagnosed by a medical doctor

Inclusion Criteria Healthy controls:

  • No low back pain

Exclusion Criteria:

  • Insufficient understanding of Dutch language
  • Previous spinal surgery
  • Chronic Obstructive Lung Disease, Interstitial Lung Disease, pulmonary vascular disease, asthma except for exertional asthma
  • Acute cardiovascular or gastrointestinal disorders
  • Neuromuscular disease interfering with normal lower limb or trunk functioning
  • Acute pain or secondary chronic pain
  • Pregnant and lactating women
  • Major psychiatric conditions
  • Acute lower limb problems
  • Vestibular disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: Healthy controls
assessment of hyperventilation, postural control and psychological behavior
Active Comparator: Patients with low back pain
assessment of hyperventilation, postural control and psychological behavior

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nijmegen questionnaire
Time Frame: Day 1
Questionnaire evaluating hyperventilation symptoms, 16 items, total score range 0-64
Day 1
Nijmegen questionnaire
Time Frame: Day 4
Questionnaire evaluating hyperventilation symptoms, 16 items, total score range 0-64
Day 4
PetCO2
Time Frame: Day 1
End-tidal carbon dioxide pressure measured with a capnograph
Day 1
Postural control
Time Frame: Day 1
upright standing balance measured by center of pressure by force plate
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Breathing frequency
Time Frame: Day 1
amount of breaths per minute, inspiratory and expiratory time
Day 1
Breathing pattern (abominal and thoracic)
Time Frame: Day 1
abdominal or thoracic contribution to one breath measured by respiratory inductance plethysmography
Day 1
Numerical Rating Scale for low back pain (NRS)
Time Frame: Day 1
11 point Likert scale evaluating severity/intensity of back pain, ranging from 0 (no pain) to 11 (worst pain imaginable)
Day 1
Oswestry Disability Index version 2.1a (ODI-2.1a)
Time Frame: Day 1
Questionnaire evaluating disability. 10 items Total score range from 0-100
Day 1
12-item Short form Health Survey (SF-12)
Time Frame: Day 1
Questionnaire evaluating physical and mental components of health related quality of life. 12 items. Total score range 12-56.
Day 1
Fear Avoidance Component Scale (FACS)
Time Frame: Day 1
Questionnaire evaluating fear-avoidance related to pain. 20 items Total score range from 0-100
Day 1
Tampa Scale for Kinesiophobia (TSK)
Time Frame: Day 1
Questionnaire evaluating kinesiophobia related to pain. 17 items. Total score range from 17-68
Day 1
Pain Catastrophizing Scale (PCS)
Time Frame: Day 1
Questionnaire evaluating catastrophizing. 13 items, 5 point Likert scale. Total score 0-52
Day 1
Need for Controllability and Predictability Questionnaire (NCP-Q)
Time Frame: Day 1
Questionnaire evaluating the need for being able to control and predict situations. 15 items, 5 point Likert scale. Total score range 15 - 75
Day 1
Positive And Negative Affect Schedule (PANAS)
Time Frame: Day 1
Questionnaire evaluating positive and negative affect. 10 items positive affect, 10 items negative affect, 5 point Likert scale. Total score range per affect: 10 - 50
Day 1
Pain Solutions Questionnaire (PaSoL)
Time Frame: Day 1
Questionnaire evaluating assimilative and accommodative responses to problems associated with pain. 14 items, 7 point Likert scale. Total score range 0 - 84
Day 1
Toronto Alexithymia Scale 20 (TAS-20)
Time Frame: Day 1
Questionnaire evaluating characteristics linked to alexithymia. 20 items, 3 factors. Total score range 20 - 100
Day 1
Interoceptive Awareness Questionnaire (IAQ)
Time Frame: Day 1
Questionnaire evaluating adaptive and maladaptive body awareness. 19 items, 5 point Likert scale.
Day 1
Fremantle Back Awareness Questionnaire (FreBAQ)
Time Frame: Day 1
Questionnaire evaluating back specific perceptual awareness. 9 items, 5 point Likert scale. Total score range 0-36
Day 1
Vragenlijst belastende ervaringen (VBE) - short version
Time Frame: Day 1
Questionnaire evaluating aversive experiences in adult life. 11 items should be scored with yes or no. If yes a score on a 5 point Likert scale should be given.
Day 1
Multidimensional Perfectionism Scale (MPS)
Time Frame: Day 1
Questionnaire evaluating adaptive and maladaptive perfectionism. 35 items, 5 point Likert scale. Total score range 35 - 175
Day 1
International Physical Activity Questionnaire - Short Form (IPAQ-SF)
Time Frame: Day 1
Questionnaire evaluating subjective level of physical activity. 7 questions regarding amount of time spent on certain activities.
Day 1

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart rate
Time Frame: Day 1
ECG measurement to determine heart rate variability
Day 1
Skin conductance
Time Frame: Day 1
The resistance / conductance of the skin, stress physiological measure
Day 1
Activity of abdominal muscles
Time Frame: Day 1
The amount of muscle activation measured by electromyography
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

ZOL

Investigators

  • Principal Investigator: Lotte Janssens, PhD, PT, Hasselt University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2020

Primary Completion (Estimated)

July 1, 2024

Study Completion (Estimated)

July 1, 2024

Study Registration Dates

First Submitted

August 28, 2019

First Submitted That Met QC Criteria

August 28, 2019

First Posted (Actual)

August 30, 2019

Study Record Updates

Last Update Posted (Actual)

September 28, 2023

Last Update Submitted That Met QC Criteria

September 26, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain, Recurrent

Clinical Trials on assessment of hyperventilation, postural control and psychological behavior

3
Subscribe